The company is engaged in advanced noninvasive neurostimulation treatments for mental health disorders, including major depressive disorder, obsessive-compulsive disorder, and smoking addiction, with additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders underway. BrainsWay is dedicated to leading through superior science and building on its unparalleled body of clinical evidence, with the latest news and information available on their website.